SenesTech (NASDAQ:SNES – Get Free Report) issued its earnings results on Wednesday. The company reported ($1.22) EPS for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28, Zacks reports. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. The company had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.71 million.
SenesTech Stock Up 4.3 %
Shares of SNES opened at $2.40 on Friday. The company’s 50-day moving average price is $3.06 and its 200 day moving average price is $2.86. SenesTech has a 12-month low of $1.90 and a 12-month high of $9.80. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32.
Analysts Set New Price Targets
Several research firms have recently commented on SNES. StockNews.com began coverage on shares of SenesTech in a research report on Sunday, March 9th. They set a “sell” rating on the stock. HC Wainwright lifted their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Undervalued Stocks You Can Buy at a Discount Now
- NYSE Stocks Give Investors a Variety of Quality OptionsÂ
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How is Compound Interest Calculated?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
